The combination of prednisolone and cinchocaine is the active ingredient of
Scheriproct ointment (Nappi code: 762660-007, 015) & Scheriproct
suppositories (Nappi code: 875384-005).
The combination of prednisolone and cinchocaine
has an anti-haemorrhoidal effect. Anti-haemorrhoidals are drugs that relieve and
reduce the symptoms of haemorrhoids, a condition associated with swelling and
inflammation of veins in the rectum and anus.
In South Africa this combination is registered for the treatment of
short-term symptomatic relief of haemorrhoids, anal fissure (a small tear in the
anus), and anal itching.
This medication does not cure the underlying condition, but simply keeps the
symptoms under control. For it to be effective, it has to be taken regularly.
Straining during defecation should furthermore best be avoided.
It is advised not to continue treatment for longer than 7 days to prevent
systemic side effects associated with both active ingredients found in this
How does this combination work?
Cinchocaine numbs the area where
the medication has been applied, relieving pain and itching, while prednisolone
- a corticosteroid - reduces inflammation, swelling and irritation.
Available as: this combination is available as
both suppositories and as an ointment.
What does it do? This
combination relieves the symptoms associated with haemorrhoids, and related skin
conditions in the anal and rectal region.
Dependence risk: low
Is this combination available as a
Is this combination available on prescription only?
Stopping this medicine: complete the
course as directed by your doctor.
Prolonged use: this product is not
intended for long-term use.
Consult your doctor before using this
- you have an untreated viral, fungal or secondary bacterial in the
- you are allergic to local anaesthetics
- you are experiencing rectal bleeding
- you are pregnant
Pregnancy: avoid. Potential risk to the foetus has been
reported. Consult your doctor before use, or if you are planning to fall
avoid. It is unknown how this medication may
affect your baby. Consult your doctor before use.
Porphyria: avoid. It
is unknown how this medication may affect your condition. Consult your doctor
Infants and children: this medication is not intended for
use in children.
The elderly: no special precautions need to be
Possible side effects
Only if severe
In all cases
|thinning of the skin in the anal region
Interactions are not expected at the prescribed dosage and
duration of treatment.
A small overdose is no cause for
concern. In case of intentional large overdose, seek emergency medical
Adults, suppositories :insert one
suppository per rectum daily. Ointment: clean the affected area and apply twice
daily as needed.
This material is not intended to substitute medical advice,
but is for informational purposes only. Please consult a physician for specific
treatment and recommendations.